Knowing your demographics and market sizes is always important. This news article has been making the rounds on all biotech newsletters, but I still thought it is worth a mention.
The current lead markets in the world are supposed to be the US, Europe and Japan, with Australia hovering around there somewhere. Given this scenario, it is also interesting to see how Europe divvies up as a market, in terms of the individual countries.
Research and Markets, pegs the three nations as follows
Germany > France > UK ($5.6bn USD).
The article further points out past problems and future projections for the UK market that are quite interesting.
Add to Onlywire
No comments:
Post a Comment